The Chemours Co (NYSE:CC)

Q2 2026 Chemours Co Earnings Call Transcript

Aug 5, 2026 / 12:00 PM GMT

Release Date Price: $14.59 (-18.63%)

Transcript 10-Q8-K

Key Points

Positve

Adjusted EBITDA exceeded expectations, supported by stronger operational performance and improved product mix in APM, lower corporate costs, and pricing strength in TT.
Pricing improved across all businesses, including a 5% year-to-date price increase in TT and continued execution of global TIO2 price hikes.
Performance Solutions portfolio in APM grew net sales 8% year-over-year, driven by strong demand in data center and semiconductor end markets.
Strong cash generation enabled further debt reduction, with $270 million repaid on the term loan in Q2, improving financial flexibility.
Progress on resolving legacy litigation, including settlements with the U.S. EPA and West Virginia DEP, de-risks the balance sheet.
Early sales of two-phase liquid cooling products and a 70% year-over-year increase in product trials signal growth in AI infrastructure markets.
TSS delivered solid results with year-over-year adjusted EBITDA growth and margin expansion despite softer aftermarket demand.
TT pricing momentum is more than offsetting inflationary cost headwinds, with volumes expected to be up year-over-year in the second half outside China.
APM's Washington Works outage is resolved, and the company expects a return to normal operating levels, supporting Q3 sequential sales growth.
Management reaffirmed long-term targets of at least $1 billion annual adjusted EBITDA and free cash flow conversion exceeding 40%.

Negative

Net sales were slightly below expectations due to softer residential stationary AC demand in TSS.
TSS aftermarket is experiencing elevated inventory levels and destocking, leading to a 25% drop in aftermarket volumes year-over-year.
Third-quarter TSS net sales are expected to decline sequentially by mid-teens to 20%, with adjusted EBITDA guided lower at $125-$140 million.
TT volumes were lower across key markets, with only Asian markets (excluding China) and Latin America showing resilience.
APM net sales declined year-over-year due to the SPS capstone line closure and higher costs from the Washington Works outage.
Full-year 2026 adjusted EBITDA guidance was reduced to $775-$825 million, reflecting weaker TSS aftermarket demand.
The company faces ongoing inflationary cost pressures, particularly in TT, which partially offset pricing gains.
Residential demand is pressured by higher interest rates, affordability challenges, and a slower housing market, impacting TSS.
The aftermarket destocking is expected to continue through the year, with normalization not expected until 2027.
Free cash flow conversion is guided above 25% for 2026, below the long-term target of 40%, due to litigation payments and other costs.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CC.N - The Chemours Company
Q2 2026 Chemours Co Earnings Call
Aug 05, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning.

My name is Therese and I will be your conference operator today.

I would like to welcome everyone to the Chemours Company's second quarter 2026 results conference call.

Currently, all participants are in a listen-only mode.

A question-and-answer session will follow the conclusion of the prepared remarks.

I would like to remind everyone that this conference call is being recorded.

I would now like to hand the conference call over to Brandon Anchez, Vice President and Head of Strategy and Investor Relations for Chemours.

You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.